Chrome 2001
.
Aetna Intelihealth InteliHealth Aetna Intelihealth Aetna Intelihealth
 
.
. .
.
Chrome 2001
Chrome 2001
Health News Health News
.
Implanted Monitor May Help Spot Dangerous Heart Rhythm After Stroke
February 14, 2014

 

FRIDAY, Feb. 14, 2014 (HealthDay News) -- Atrial fibrillation is a common and potentially deadly form of irregular heartbeat that's often tough to detect. Now researchers say that an implantable heart monitor may help spot the disorder in patients who've suffered a unexplained stroke.

Atrial fibrillation "causes blood clots to form in the heart that ultimately travel to the brain and lead to a stroke," explained Dr. Erik Altman, director of electrophysiology at North Shore-LIJ's Southside Hospital in Bay Shore, N.Y.

He was not connected to the study, which was to be presented Friday at the American Stroke Association's International Stroke Conference in San Diego.

According to background information provided by the study authors, people with atrial fibrillation have about a fivefold higher risk of stroke, but medicines can reduce that risk if the abnormality is spotted early on.

However, "atrial fibrillation can be difficult to detect due to its sometimes intermittent nature, and the fact that it isn't always accompanied by symptoms," study author Dr. Richard Bernstein, a professor of neurology at Northwestern University, said in a stroke association news release.

"For a patient who has had an unexplained stroke, it's really important to determine if they have atrial fibrillation, because left untreated it could result in a second, and even more devastating, stroke," he added.

The new study included 441 patients from 55 centers in North America and Europe with unexplained stroke. About half of them underwent standard testing, while the other half received a small heart monitor that was implanted under the skin and provided doctors with continuous data on heart rhythm for up to three years.

The Reveal XT monitor proved six to seven times more effective at detecting atrial fibrillation than standard testing, according to the study , which was paid for by the device's maker, Medtronic.

After six months, atrial fibrillation was detected in nearly 9 percent of patients with the implantable monitor, compared to 1.4 percent of those who had standard testing. After one year, those rates were 12.4 percent and 2 percent, respectively. After three years, the rates were 30 percent and 3 percent, respectively.

"Finding atrial fibrillation after a stroke changes therapy from the aspirin class of drugs, which are not very effective in atrial fibrillation, to anticoagulants [stronger blood thinners]," Bernstein explained.

Ninety-seven percent of the patients in the study who were found to have atrial fibrillation were prescribed blood thinners.

Another expert noted that cardiac monitors have been around for a while.

"The technology has been available for several years and is useful for the detection of heart rhythm disturbances that are too infrequent to be found using conventional methods, such as an electrocardiogram or a heart monitor that is worn for a day or two," explained Dr. Kenneth Ong, interim chief of cardiology at The Brooklyn Hospital Center in New York City.

"Because it is inserted under the skin, the monitor continually senses each heartbeat and can detect abnormal rhythms over long periods of time," added Ong, who was not involved with the new study.

He called the implantable monitor "another tool that physicians can use in evaluating patients with a recent stroke. "

However, Ong also cautioned that every medical technology carrries some level of risk.

"As the study also reports, this is an invasive approach and therefore has complications such as infection and breakdown of the tissue around the monitor," he said. "It should not be the first test for these patients, but needs careful evaluation before recommending its use."

In the study, 2 percent of the devices were removed because of complications.

Findings presented at medical meetings are typically considered preliminary until published in a peer-reviewed journal.

More information

The U.S. National Heart, Lung, and Blood Institute has more about atrial fibrillation.Copyright © 2014 HealthDay. All rights reserved.


SOURCES: Erik Altman, M.D, director, electrophysiology, North Shore-LIJ's Southside Hospital, Bay Shore, N.Y.; Kenneth Ong, M.D, interim chief, cardiology, The Brooklyn Hospital Center, New York City; American Stroke Association, news release, Feb. 14, 20...

InteliHealth
.
.
.
.
.
More News
InteliHealth .
.
General Health News
Today's News
Today In Health History
This Week In Health
Addiction News
Allergy News
Alzheimer's News
Arthritis News
Asthma News
Babies News
Breast Cancer News
Bronchitis News
Cancer News
Cervical Cancer News
Children's Health News
Cholesterol News
Dental/Oral Health News
Depression News
Diabetes News
Ear, Nose And Throat News
Environmental Health News
Eye News
Fitness News
Genetics News
Headache News
Health Policy News
Heart Attack News
Heart Failure News
Heart Health News
HIV/AIDS News
Infectious Diseases News
Influenza News
Lung Cancer News
Medication News
Men's Health News
Mental Health News
Multiple Sclerosis News
Nutrition News
Parkinson's News
Pregnancy News
Prostate Cancer News
Schizophrenia
Senior Health News
Sexual/Reproductive Health News
Sexual dysfunction
Sleep News
STDs News
Stroke News
Tobacco Cessation News
Weight Management News
Women's Health News
.
.
.
.
InteliHealth
    Print Printer-friendly format    
   
.  
This website is certified by Health On the Net Foundation. Click to verify.
.